We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Reducing Chloride in IV Fluids May Improve Renal Outcomes

By HospiMedica International staff writers
Posted on 29 Oct 2012
A new study suggests that chloride-restrictive intravenous (IV) fluid strategy could reduce acute kidney injury (AKI) in the intensive care unit (ICU).

Researchers at Austin Hospital (Melbourne, VIC, Australia) conducted a prospective study of 1,533 patients (773 intervention patients, 760 controls) admitted consecutively to the ICU. More...
During the control period, patients received standard IV fluids; after a 6-month phase-out period, any use of chloride-rich IV fluids (0.9% saline, 4% succinylated gelatin solution, or 4% albumin solution) was restricted to attending specialist approval. Patients instead received a lactated solution (Hartmann solution), a balanced solution (Plasma-Lyte 148), and chloride-poor 20% albumin. The primary outcome measures included peak creatinine level and incidence of AKI. Other outcomes included the need for renal replacement therapy (RRT), length of stay in ICU and hospital, and survival.

The results showed that the change in IV chloride levels was associated with a significantly smaller mean serum creatinine level increase (14.8 versus 22.6 µmol/L), a lower rate of AKI as defined by to the risk, injury, failure, loss, end-stage (RIFLE) classification (8.4% versus 14%), and a lower rate of renal replacement therapy use (6.3% versus 10%). After adjustment for potential confounders, the rates of AKI and RRT were both a relative 48% lower during the intervention phase. There was no difference in mortality between the control and intervention periods. The study was published in the October 17, 2012, issue of the Journal of the American Medical Association (JAMA).

“These findings, together with the previously reported observations that a chloride-liberal intravenous strategy can be associated with higher cost and the easy availability of cheap alternatives, suggest the need to exert prudence in the administration of fluids with supra-physiological concentrations of chloride, especially in critically ill patients with evidence of early acute renal dysfunction or at risk of acute dysfunction,” concluded senior author Rinaldo Bellomo, MD, and colleagues.

Traditional fluids used for hydration and resuscitation in the ICU, such as normal (0.9%) saline, 4% succinylated gelatin solution, or 4% albumin solution, usually include high concentrations of chloride. Several studies have shown that rapid infusion of normal saline during anesthesia and surgery inevitably leads to metabolic acidosis, which is associated with hyperchloremia. The same was not observed after administration of lactated Ringer's solution.
Related Links:
Austin Hospital



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Medical Examination & Procedure Light
Vega 80
New
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new Cora Torqueable Microcatheters expand our coronary portfolio supporting patients with coronary artery disease (photo courtesy of Reflow Medical)

Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions

Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.